10 January 2021 in Open Access Macedonian Journal of Medical Sciences
TMTjokorda Gde Bagus Mahadewa
Tjokorda Gde Bagus Mahadewa
+3
Spinal cord injury (SCI) is a common and potentially life-threatening condition with no established treatment to treat the primary injury. Mesenteric neural stem cell (NSC) therapy is a promising stem cell therapy to treat primary SCI in the chronic phase. We aimed to review the literature narratively to describe current evidence regarding mesenteric NSC in SCI. Primary SCI refers to tissue damage that occurs at the time of trauma that leads to the death of neuronal cells. In chronic SCI, the ability of neuronal regeneration is compromised by the development of gliotic scar. NSC is a stem cell therapy that targeted SCI in the chronic phase. Enteric NSC is one of the sources of NSC, and autologous gut harvesting in the appendix using endoscopic surgery provides a more straightforward and low-risk procedure. Intramedullary transplantation of stem cell with ultrasound guiding is administration technique which offers long-term regeneration. Mesenteric NSC is a promising stem cell therapy to treat chronic SCI with low risk and easier procedure to isolate cells compared to other NSC sources.
1 October 2025 in Caspian Journal of Neurological Sciences
Background: Aneurysms of the anterior communicating artery (AComA) are a frequent cause of subarachnoid hemorrhage. They present significant challenges in endovascular management due to complex vascular anatomy and the need to preserve critical perforating arteries. Stent-assisted coiling (SAC) has emerged as a reliable technique for wide-neck AComA aneurysms, offering favorable occlusion rates ...
1 January 2022 in Open Access Macedonian Journal of Medical Sciences
BACKGROUND: Scalenus syndrome is a collection of symptoms as the consequences of nerve and vascular compression within the scalene triangle. However, the entity has long been forgotten in publications and is difficult to recognize. The diagnosis of scalenus syndrome is mainly based on clinical findings. The Ali Shahab score is a new scoring system, generated based on clinical symptoms of scalenus syndrome. AIM: In this study, we presented a case series of scalenus syndrome patients who were diagnosed and decide to be managed surgically based on Ali Shahab score. We also reported post-operative outcomes following scalenectomy in our series. METHODS: This was a case series including patients with scalenus syndrome in Gatot Soebroto Army Hospital, Indonesia, and Siloam Asri Hospital, Indonesia, between 2016 and 2021. The diagnosis of scalenus syndrome was made based on Ali Shahab score with a value of more than 7. All patients were performed scalenectomy to decompress the stenotic subclavian artery and brachial plexus from surrounding fibrotic tissue. Eligible subjects were assessed for sex, side of symptoms, pre-operative and post-operative Ali Shahab score, and post-operative outcome. RESULTS: We included 96 patients with scalenus syndrome in this case series. Most of the included patients were male (59.4%) and experienced scalenus syndrome on the right side (76%). The average pre-operative Ali Shahab score in our series was 7.12 ± 0.48 and the post-operative score was 0.11 ± 0. Regarding post-operative outcomes, more than half of the patients experienced symptoms reduction with 38.5% of patients experiencing complete resolution of symptoms following scalenectomy. CONCLUSION: The application of the Ali Shahab score may be used as a diagnostic tool and decision of surgical management for scalenus syndrome patients. Decompression of the subclavian artery and releasing brachial plexus from surrounding fibrotic tissue can improve clinical symptoms in scalenus syndrome patients.
2 June 2025 in Journal of Neurosurgery: Case Lessons
BACKGROUND: The neurological symptoms resulting from anterior cerebral artery (ACA) occlusions can be severe, with A2/3 occlusions reported as the most functionally impairing among medium-vessel occlusions. Patients with mechanical thrombectomy failure for acute A2/3 occlusions may occasionally require microsurgical interventions. OBSERVATIONS: An 84-year-old male presented to the authors’ hospital with left lower limb paralysis. Brain CT angiography revealed a right A3 occlusion due to a calcified lesion. Alteplase was injected intravenously, and mechanical thrombectomy was performed. Navigating the aspiration catheter was difficult and the microwire was unable to pass through the lesion. Nevertheless, the authors later observed improvement in the flow of the ACA, and the paresis improved despite severe atherosclerotic stenosis. Two hours after the thrombectomy, the monoplegia deteriorated again. Therefore, the authors decided to perform microsurgical intervention. Complete ACA recanalization was achieved by performing endarterectomy for the lesion. Postoperatively, the patient was capable of walking independently. LESSONS: Microsurgical treatment is feasible for a challenging ACA occlusion with a severe calcified lesion in which an endovascular attempt is considered to be too difficult. This is the first case in which a favorable clinical outcome was reached with an emergency endarterectomy performed for A3 severe stenosis. https://thejns.org/doi/10.3171/CASE2596